Article

Communicating the Robustness of Findings of COVID-19 Studies

2020-06-12

Abstract excerpt

The COVID-19 pandemic is forcing researchers, clinicians, and policymakers to accelerate the evaluation of treatments and vaccines. Critical to these evaluations is the ability to characterize the uncertainty of inferences in clear terms accessible to a broad set of stakeholders with varying statistical backgrounds. Here we quantify the uncertainty about inferences from Randomized Controlled Trials (RCTs) by quant...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f5212747-df57-57e2-adb2-9cc84bb06276
DOI: 10.2139/ssrn.3607967

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Communicating the Robustness of Findings of COVID-19 StudiesDOI 10.2139/ssrn.3607967Read

A Bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with COVID-19Semantic proximity Read

Credible learning of hydroxychloroquine and dexamethasone effects on COVID-19 mortality outside of randomized trialsSemantic proximity Read

COVID-19 and the Generation of Novel Scientific Knowledge in a Dangerous Time.Semantic proximity Read

Statistical Decision Properties of Imprecise Trials Assessing COVID-19 DrugsSemantic proximity Read

Harmonizing heterogeneous endpoints in COVID-19 trials without loss of information –an essential step to facilitate decision makingSemantic proximity Read

Making sense of non-randomized comparative treatment studies in times of Covid-19: A case study of tocilizumabSemantic proximity Read

A plasmode simulation-based bias analysis for residual confounding by unmeasured variables leveraging information-rich subsetsSemantic proximity Read

Causal analysis of absolute and relative risk reductionsSemantic proximity Read

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trialsSemantic proximity Read

COVID-19 convalescent plasma and randomized clinical trials: explaining conflicting outcomes and finding signals of efficacySemantic proximity Read

Randomized controlled trials do not support efficacy of any of the tested doses of fluvoxamine in prevention of disease progression in adults with incipient non-severe COVID-19 disease: a case-study systematic review and meta-analysisSemantic proximity Read

Real World Evidence – Current Developments and PerspectivesSemantic proximity Read